Novartis / Allergan / Molecular Partners / Swiss Federal Laboratories / Schlieren AG / Alcon / Biogen-Idec / ESBATech / A03 Human Capital / Roche / Neurimmune / PET / Aeon / C06 Life Science Zurich Capital / /
Continent
Europe / /
Country
Germany / Switzerland / Hungary / Netherlands / Austria / United States / United Kingdom / Spain / /
Currency
CHF / USD / EUR / /
Event
M&A / FDA Phase / /
Facility
Zurich University of Applied Sciences / University Hospital / University Hospital of Zurich / Swiss Federal Institute of Technology Zurich / Balgrist Campus / University Clinic Balgrist / A11 Research hospital / Dübendorf airfield / University of Zurich / /
IndustryTerm
manufacturing facility / biotechnology / pharmaceutical industry / excellent infrastructure / e.g. joint laboratory infrastructure / life sciences network / technology transfer sites / treatment for chronic lymphocytic leukemia / strategies and tools / pharmaceutical groups / marketable products / innovation systems / required laboratory infrastructure / medical technology / ophthalmology products / pharmaceuticals industry / tighter networking / important networking platforms / antibody fragment technology / real estate partners / exemplary laboratory infrastructure / trinational network / applicable tool / therapies for Alzheimer’s disease / spin-off / in allowing tighter networking / /
Oxford/ Thames Valley / Lake Geneva / Lake Constance / /
Organization
University Hospital of Zurich / Swiss Federal Institute of Technology Zurich / ETH Innovation and Entrepreneurship Lab / University Hospital / Department of Life Sciences and Facility Management / BioLAGO association / Office for Economy / University of Zurich / Life Science Learning Center / Department for Economic Affairs / Zurich University of Applied Sciences / B01 University / Graduate School / EU Commission / FDA / European Union / University for Applied Sciences / /
Person
Mario Jenni / / /
Position
Director BIO-TECHNOPARK Schlieren-Zurich Wagistrasse / Co-founder & Managing Director / Life Science Zurich Young Scientist / /
Product
A05 / /
ProvinceOrState
Zurich / /
Region
Eastern Switzerland / northeast Switzerland / /
Technology
Health Technology / Av / tomography / Antibodies / biotechnology / radiopharmaceuticals / antibody fragment technology / http / antibody analogues / /
858 Life ScienceS START-UPS in SwiTzeRLAnd CHIMIA 2014, 68, Nr. 12 doi:chimia